Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin and omega-3 for intrauterine growth restriction
IRCT20250929067421N1Phase 3Recruiting
- Sponsor
- Kurdistan University of Medical Sciences
- Start
- Jun 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of aspirin and omega-3 fatty acid in intrauterine growth restriction (IUGR) and high-risk pregnancy, sponsored by Kurdistan University of Medical Sciences. Started Jun 2026; status: recruiting.
02
Drugs
aspirinomega-3 fatty acid
03
Conditions
intrauterine growth restriction (IUGR)high-risk pregnancy
Beyond the preview
Go deeper on IRCT20250929067421N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250929067421N1.